Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Charles River Laboratories logoCharles River Laboratories CRL

The company said it reported in the Form 8-K filed on September 16, 2025 the resignation of Flavia H. Pease as Chief Financial Officer and the appointment of Michael G. Knell as interim Chief Financial Officer. This 8-K/A is to disclose details of Mr. Knell's compensation that were not determined at the time of the original filing.

8-K/ADeparture or Appointment of Directors or Certain Officers (amended)Amended filingFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said it reported in the Form 8-K filed on September 16, 2025 the resignation of Flavia H. Pease as Chief Financial Officer and the appointment of Michael G. Knell as interim Chief Financial Officer. This 8-K/A is to disclose details of Mr. Knell's compensation that were not determined at the time of the original filing.

  2. The company said the Compensation Committee approved an increase in annual base salary to $500,000 in connection with Mr. Knell's appointment as interim Chief Financial Officer on September 15, 2025. The increase is effective September 28, 2025.

  3. The company said it approved a monthly cash payment of $10,000 to be paid during Mr. Knell's term of service as interim Chief Financial Officer, effective October 1, 2025.

  4. The company said it approved a one-time grant of restricted stock units with a grant value of $500,000 to be granted on November 6, 2025, with 50% to vest on the 1st anniversary of the grant date and the remaining 50% to vest on the 2nd anniversary of the grant date.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Amendment filed to disclose interim CFO compensation details

The company said it reported in the Form 8-K filed on September 16, 2025 the resignation of Flavia H. Pease as Chief Financial Officer and the appointment of Michael G. Knell as interim Chief Financial Officer. This 8-K/A is to disclose details of Mr. Knell's compensation that were not determined at the time of the original filing.

Source · Based on the filing body and exhibits

Interim CFO annual base salary increased to $500,000

The company said the Compensation Committee approved an increase in annual base salary to $500,000 in connection with Mr. Knell's appointment as interim Chief Financial Officer on September 15, 2025. The increase is effective September 28, 2025.

Source · Based on the filing body and exhibits

Interim CFO to receive monthly cash payment of $10,000

The company said it approved a monthly cash payment of $10,000 to be paid during Mr. Knell's term of service as interim Chief Financial Officer, effective October 1, 2025.

Source · Based on the filing body and exhibits

Restricted stock units grant of 1 with 2-tranche vesting schedule

The company said it approved a one-time grant of restricted stock units with a grant value of $500,000 to be granted on November 6, 2025, with 50% to vest on the 1st anniversary of the grant date and the remaining 50% to vest on the 2nd anniversary of the grant date.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.